Endo-Adts gene therapy
Latest Information Update: 30 May 2001
At a glance
- Originator Nonindustrial source
- Class Analgesics; Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 02 Sep 1998 No-Development-Reported for Pain in USA (Unknown route)
- 16 Dec 1996 New profile